Sort
326,823 grants matching “clinical trial”
Center for Suicide Research and Prevention
$3,293,893Jordan W Smoller · Massachusetts General Hospital · P50 · FY2025 · MH
HPTN - CENTRAL LABORATORY
$3,293,072Johns Hopkins University · U01 · FY2003 · AI
EARLY TMT/RETINOPATHY OF PREMATURITY (ETROP)- COORD CTR
$3,291,619University Of Texas Hlth Sci Ctr Houston · U10 · FY2002 · EY
PHASE 1 CLINICAL TRIAL USING AUTOLOGOUS, MUC1-ACTIVATED T CELLS EXPANDED FROM PERIPHERAL BLOOD IN PATIENTS WITH RELAPSED AND RESISTANT OVARIAN CANCER
$3,291,419Mayo Clinic Arizona · · FY2025 · Defense Health Agency
Sequential Trial of Adding Buprenorphine, Cognitive Behavioral Treatment, and Transcranial Magnetic Stimulation to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (ACTION)
$3,290,624Kelly S. Barth · Medical University Of South Carolina · R01 · FY2023 · DA
DCTD Human Toxicology and Pharmacology
$3,290,376Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Neurobiological Predictors of Huntington's Disease
$3,290,022Jane S Paulsen · University Of Iowa · R01 · FY2007 · NS
Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II
$3,289,394Michael Alosco · Boston University Medical Campus · R01 · FY2024 · NS
HIV Vaccine Trials Network Laboratory Center - B-Cell and Molecular Assay Multi-year Supplement
$3,287,548Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2024 · AI
Buffalo Clinical and Translational Research Center
$3,287,496Timothy F Murphy · State University Of New York At Buffalo · UL1 · FY2017 · TR
IND-enabling studies and phase I clinical trials to advance CD74-target, DRhQ, as a treatment for stimulant use disorder
$3,287,052Renee Lynn Shirley · Virogenomics Biodevelopment, Inc. · UG3 · FY2025 · DA
DCTD Computer Support
$3,286,993David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE
$3,286,257Reisa A. Sperling · University Of California, San Diego · U19 · FY2016 · AG
Pharmacogenomics and Risk of Cardiovascular Disease
$3,286,210Children'S Hospital &Res Ctr At Oakland · U01 · FY2005 · HL
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$3,286,124Scott M Hammer · Columbia University Health Sciences · U01 · FY2007 · AI
Cell and Molecular Basis for Congenital Heart Disease
$3,285,915Cecilia W Lo · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Pharmacogenetics of Asthma Treatment
$3,285,718Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2006 · HL
Molecular Targets of Germinal Center B Cell Lymphomas
$3,285,136Dana-Farber Cancer Institute · P01 · FY2005 · CA
DCTD Cancer Imaging
$3,284,762David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Physiology, Psychology, and Genetics of Obesity
$3,284,702Jack A. Yanovski · Child Health And Human Development · Z01 · FY2007 · HD
HIV, TB, and Malaria Vaccine Development for Africa
$3,284,182Barton F Haynes · Duke University · P01 · FY2007 · AI
A novel therapeutic to ameliorate chronic pain and reduce opiate use
$3,283,785Boris Tabakoff · Lohocla Research Corporation · UH3 · FY2022 · DA
Multimodal MRI in Multiple Sclerosis
$3,283,709Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: The KidsCanSeq Study
$3,283,327Sharon Emma Plon · Baylor College Of Medicine · U01 · FY2019 · HG
UW Multidisciplinary Clinical Research Training (RMI)
$3,282,638Richard A Deyo · University Of Washington · K12 · FY2006 · RR